The Journal of Urology
Volume 180, Issue 6 , Pages 2299-2300, December 2008

Are We Overtreating Prostate Cancer?

  • Judd W. Moul

      Affiliations

    • Financial interest and/or other relationship with AstraZeneca and Sanofi Aventis.

Division of Urologic Surgery and Duke Prostate Center, Duke University Medical Center, Durham, North Carolina

published online 20 October 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-5347(08)02587-1

doi:10.1016/j.juro.2008.09.067

The Journal of Urology
Volume 180, Issue 6 , Pages 2299-2300, December 2008

Article Tools